UPDATE: Presentations now available (see below)
MEPs, national health attachés, organizations involved in EPAAC, and other policy makers discussed the future of the cancer partnership and potential further legislative action against cancer on Wednesday, 29 September at the European Parliament at the first formal MAC (MEPs Against Cancer) meeting, hosted by MEPs Alojz Peterle and Liz Lynne and supported by ECL providing the new MAC Secretariat.
This important meeting focused on the following areas:
The keynote speech was made by Ms Paola Testori Coggi, Director General, DG Health and Consumers
Presentations were as follows (click to download presentations):
Official invitation from MEP Alojz Peterle to the MAC meeting:
It is with great pleasure for me and all fighters against cancer to inform you about the re-establishment of MAC (MEPs against Cancer) group in the European Parliament (EP). MAC has been instrumental in bringing cancer back into the EU agenda as a priority for action. The group inspired the EP to adopt a Resolution on combating cancer in the enlarged EU; this in turn led to all EU Health Ministers endorsing the Council Cancer Conclusion under the Slovenian EU Presidency. Following such strong political commitment from two EU institutions, the European Commission launched the European Partnership Action against Cancer (EPAAC) on 24 September in Brussels. This is a tremendous opportunity for the European Parliament to get involved and to ensure that the Partnership improves outcomes in our countries.
MAC was successful at raising the awareness of the political fight against cancer. The incidence of cancer is still increasing dramatically and is becoming the major killer in Europe. This is unacceptable to us politicians and to our citizens.
At our first meeting this year we decided that, in order to support the Prevention pillar of the EPAAC, the MAC group would have a primary focus on prevention. We will, however, certainly pay attention to the other cancer issues at the European and especially national level. I am convinced that members of the MAC group can reinforce the Partnership against Cancer, in particular in the area of relations between the European institutions and national parliaments. Therefore in addition to MEPs, national health attachés and organizations involved in EPAAC are all invited to discuss the future of the partnership and potential further legislative action against cancer.
President, MAC (MEPs Against Cancer)